Elevance Health, Inc.
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health Total Carelon — GAAP Operating Gain by Year
Total Carelon — GAAP Operating Gain ($M)
Elevance Health Total Carelon — GAAP Operating Gain: $3,378M in FY2025, up 16.9% from a year earlier.
Latest, FY2025
3,378
Period ended Dec 31, 2025
Change on a year earlier
+16.9%
2,889 in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below
Where the FY2025 figure comes from
“|| Operating gain (loss) | $ | 4,158 | $ | 2,418 | $ | 960 | $ | 3,378 | $ | ( 337 ) | $ | — | $ | 7,199”
Source: 10-K (FY2025, 2026-02-06) ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Carelon — GAAP Operating Gain ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,378 | +16.9% | 10-K (FY2025, 2026-02-06) ↗ |
| FY2024 | Dec 31, 2024 | 2,889 | +8.8% | 10-K (FY2025, 2026-02-06) ↗ |
| FY2023 | Dec 31, 2023 | 2,655 | +10.5% | 10-K (FY2025, 2026-02-06) ↗ |
| FY2022 | Dec 31, 2022 | 2,403 | +28.4% | 10-K (FY2024, 2025-02-20) ↗ |
| FY2021 | Dec 31, 2021 | 1,871 | – | 10-K (FY2023, 2024-02-21) ↗ |
Breakdown
What makes up total Carelon — GAAP Operating Gain
Cite this data
StockData. (2026). Elevance Health Total Carelon — GAAP Operating Gain ($M), annual FY2021–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg-op-gain-carelon-total
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.